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Abstract: The understanding of the mechanisms behind nucleotide recognition by 
Argonaute 2, core protein of the RNA-induced silencing complex, is a key aspect in the 
optimization of small interfering RNAs (siRNAs) activity. To date, great efforts have been 
focused on the modification of certain regions of siRNA, such as the 3'/5'-termini and the 
seed region. Only a few reports have described the roles of central positions flanking the 
cleavage site during the silence process. In this study, we investigate the potential correlations 
between the thermodynamic and silencing properties of siRNA molecules carrying, at 
internal positions, an acyclic L-threoninol nucleic acid (aTNA) modification. Depending on 
position, the silencing is weakened or impaired. Furthermore, we evaluate the contribution of 
mismatches facing either a natural nucleotide or an aTNA modification to the siRNA 
potency. The position 11 of the antisense strand is more permissive to mismatches and aTNA 
modification, in respect to the position 10. Additionally, comparing the ON-/OFF-target 
silencing of central mismatched siRNAs with 5'-terminal modified siRNA, we concluded: 
(i) central perturbation of duplex pairing features weights more on potency rather than 
silencing asymmetry; (ii) complete bias for the ON-target silencing can be achieved with 
single L-threoninol modification near the 5'-end of the sense strand. 
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1. Introduction 
RNA interference (RNAi) is a powerful gene regulatory process that allows the inhibition of genes 
in a very specific way [1]. Double stranded RNAs known as small interfering RNAs (siRNAs), 
recognized by the RNA-Induced Silencing Complex (RISC) [2], efficiently trigger the RNAi pathway. 
After siRNA loading into the RISC, the sense strand is cleaved and released [3]. At this stage, the 
active RISC, bearing only the antisense strand, can match with the corresponding complementary 
messenger RNA (mRNA) sequence. The cleavage of the target mRNA mediates the inhibition of the 
mRNA translation into the corresponding protein. 
The great therapeutic potential of blocking the expression of specific genes [4] makes the  
siRNA-based approach, together with other nucleic acids based technologies, such as antisense 
oligonucleotides, aptamers, and exon-skipping oligonucleotides, emerging drugs for the treatment of 
cancer diseases [5,6]. Despite the promising benefits, oligonucleotides have some disadvantages, such as 
poor nuclease stability, poor cellular uptake, off-target effects, and non-specific immune responses [7,8]. 
To overcome these important hurdles, the chemical modification strategy was widely used. For 
example, the introduction of sugar phosphate backbone modifications usually increases stability to 
nucleases [9–11]. In addition, some of these modifications can also affect the conformational equilibrium 
and the overall flexibility of nucleic acid duplexes [12]. 
Hereafter, conformational restricted nucleosides, such as locked nucleic acids (LNA) [13,14], 
carbocyclic pseudonucleosides [15], arabino nucleic acids (ANA) [16], and 2'-F-ANA [17], imposing 
restriction of the conformation of the furanose system in the North quadrant of the pseudorotational 
cycle (C3'-endo, RNA-like sugar pucker) and stabilizing the A-form of RNA duplex, have been  
used to avoid off-target effects enhancing the specific recognition by the RISC. The development of 
unlocked nucleic acids (UNA) [18,19], threoninol nucleic acids (aTNA) [20,21], and serinol nucleic 
acids (SNA) [22,23] (Figure 1) has demonstrated that also more flexible acyclic derivatives can increase 
stability towards nucleases and, in addition, the introduction of these modifications at certain positions of 
siRNA molecule may improve some pivotal biological properties such as the potency [18,24]. 
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Figure 1. Chemical structures of flexible acyclic derivatives of nucleosides used in  
RNA interference experiments. Threoninol and serinol nucleic acids may be formed by  
D or L stereoisomers. 
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Likewise, thanks to chemical modifications, the RISC functionality and the role of the Ago2 
domains (the core protein of the RISC), have been successfully unveiled [9,25,26]. Such findings 
allowed the designing of tailored siRNA molecules, avoiding some pivotal off-target effects like  
non-specific silencing seed-mediated, misloading of the sense strand, induction of interferon response, 
and saturation of the RNAi machinery. Specifically, it has been described that (i) the 5'-end 
phosphorylation of the antisense strand (Figure 2) is important for the recognition of the MID domain 
of the Ago2 protein and for the proper functionality of the siRNA molecule [27]; (ii) the stretch 2–8 of 
the antisense strand, called seed region, influences the miRNA-like silencing and that its extensive 
modification should lead to more specific silence [28]; (iii) the 3'-end overhang of the antisense strand 
is recognized by the PAZ domain and the presence of bulky modifications on positions 20 and 21 
could affect the potency [29]; and (iv) the presence of modifications close to the cleavage site, 
especially at positions 10 and 11 of the antisense strand, may induce a strong impact in siRNA-mediated 
silencing [30–32]. 
 
Figure 2. Schematic representation of a 21-mer siRNA duplex. The upper strand is the 
sense (SS), the lower strand is the antisense (AS) that guides the cleavage of the cognate 
mRNA. Only one of the two strands is retained into the Ago2 protein (the antisense), the 
sense strand is cut and degraded. 
Of special concern about RNA interference is the reduction of the off-target effects [33]. One 
important source of these off-target effects comes from the wrong selection of the antisense strand by 
RISC. The selection of the strand, that will guide the silence, depends on the relative thermodynamic 
stabilities of the two ends of the siRNA duplex. The strand with the less stable 5'-end is preferentially 
incorporated into the RISC [34,35]. For this reason, it has been described that the seed-region (positons 
2–8 of the antisense strand) should be A-T rich, as the weaker base-pairing stability increases the 
probability of being selected by the RISC to form the silencing complex [36,37]. Here, as an extension 
of previous work done by our group [20], we evaluated the effect of acyclic L-threoninol nucleic acid 
(aTNA) at certain positions of the siRNAs. Specifically, we have concentrated our interest at positions 
10 and 11 of the antisense strand and at position 2 of the sense strand. We studied the contribution of 
aTNA in slicing ability of the RISC and the possible correlation between the thermal stability of 
mismatches on the siRNA potency and the ON/OFF-target activity. Furthermore, we aimed to develop 
modified siRNAs able to block the sense strand activity. 
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2. Results and Discussion 
2.1. Design and Thermodynamic Properties of siRNA Carrying L-Threoninol Monomers 
In order to evaluate the effect of the introduction of L-threoninol modification on duplex stability, 
we compared the melting temperature of siRNAs bearing either a natural uridine or L-threoninol-thymine 
(TL) (Table 1). We designed 21 nt in length siRNA strands, directed against the Renilla Reniformis 
luciferase gene [15], and the TL modification was introduced at the 10th or 11th position of the 
antisense strand, as they are the positions that direct the cleavage of the target mRNA by Ago2 protein. 
The TL-modified RNA strands were synthesized using the corresponding phosphoramidite monomer [20]. 
The complementary RNA sense strands carrying all four natural bases (A, C, G, U) in front of the TL 
modification (9th or 10th position of sense strand) were also prepared to appraise the contribution of 
mismatches to the duplex stability and to study the base discrimination properties of the TL modification 
near the cutting site of Ago2 protein. 
All the possible perfect matched and mismatched siRNA duplexes were annealed and thermal 
denaturation curves were recorded. Melting temperatures (Tm) of siRNA duplexes are reported in 
Table 1. Results obtained from thermal denaturation experiments give us precious information  
about the hybridization properties of the L-threoninol-thymine modification. The introduction of  
L-threoninol-thymine modification in the middle of RNA duplexes impacted heavily on the melting 
temperature. We observed that a single L-threoninol-thymine modification, placed either at positions 
10 or 11, induced a decrease on the melting temperature of 8.7 and 9.5 °C with respect to a perfectly 
matched RNA duplex. Then, we evaluated the impact of all possible mismatches facing either natural 
uridine or the TL modification. Thermal denaturation experiments revealed that, in the case of mismatches 
facing a natural uridine, the reduction of melting temperature depends on the nature of the mismatch 
(Table 1 and Figure 3B). The pyrimidine:pyrimidine mismatches (U:U and U:C) severely affected  
the stability of the RNA duplex and the melting temperature decreased in the range of about 7–9 °C. 
Conversely, the pyrimidine:purine (U:G) mismatch (wobble base pair) [38], was characterized by  
a small variation of the melting temperature: 2.1 and 3.5 °C difference with respect to the natural U:A 
base pair. 
Unlike the natural uridine, the melting temperature of RNA duplexes, containing mismatches facing 
TL, decreased homogenously (in the range of 3 °C), with respect to the perfect matches siRNA 
containing TL monomer. The formation of the base pair (TL:G) had a positive effect on the melting 
temperature, which was quite similar to the perfect matched RNA bearing TL. Notably, the TL modification 
suffers the effect of the presence of mismatches less. Even in the presence of hard mismatches such as 
pyrimidine:pyrimidine pairs, the decrease of the melting temperatures was not as drastic as noted in the 
case of a natural uridine. 
The observed weaker Tm variation should probably proceed from a marked capacity of accommodation 
within the double-helix in presence of any mispair. The lack of sugar constraint makes the TL 
modification sufficiently flexible to adjust its conformation into the duplex and be unable to 
discriminate among different mismatches. 
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Table 1. Design and properties of siRNA targeting Renilla luciferase gene. 
TTAAAAAGAGGXYGAAGUCUA-5' sense (SS) 
         5'-UUUUUCUCCZWCUUCAGAUTT antisense (AS) 
 
Antisense 
..ZW.. 
Sense  
..XY.. 
IC50 (pM) ± SD Tm (°C) ± SD ΔTm (wt) ΔTm (Parent) 
wt ..UU.. ..AA.. 9.6 ± 0.5 67.8 ± 0.3 -- -- 
wtU9 ..UU.. ..AU.. 15.4 ± 0.7 60.4 ± 0.2 7.6 7.6 
wtC9 ..UU.. ..AC.. 30.7 ± 0.6 59.5 ± 0.4 8.5 8.5 
wtG9 ..UU.. ..AG.. 15.8 ± 0.2 65.9 ± 0.2 2.1 2.1 
wtU10 ..UU.. ..UA.. No active 58.2 ± 0.4 9.6 9.6 
wtC10 ..UU.. ..CA.. No active 60.0 ± 0.1 7.8 7.8 
wtG10 ..UU.. ..GA.. 101 ± 0.7 64.5 ± 0.6 3.5 3.5 
T10A10 ..TLU.. ..AA.. 111 ± 0.8 58.3 ± 0.3 9.5 -- 
T11A9 ..UTL.. ..AA.. 20.2 ± 0.6 59.1 ± 0.3 8.7 -- 
T10U10 ..TLU.. ..UA.. 216 ± 0.6 55.2 ± 0.1 12.6 3.1 
T10C10 ..TLU.. ..CA.. 277 ± 0.9 54.1 ± 0.4 13.7 4.2 
T10G10 ..TLU.. ..GA.. 110 ± 0.9 55.7 ± 0.3 10.8 1.3 
T11U9 ..UTL.. ..AU.. 35.6 ± 0.4 56.4 ± 0.2 11.4 2.7 
T11C9 ..UTL.. ..AC.. 57.3 ± 0.5 55.6 ± 0.2 12.2 3.5 
T11G9 ..UTL.. ..AG.. 26.5 ± 0.8 58.4 ± 0.5 9.4 0.7 
 
Figure 3. (A) IC50 assessments of siRNA molecules. To achieve the IC50 values, HeLa 
cells were co-transfected with psiCHECK2 (AS) reporter and decreasing amounts (1 nM,  
0.3 nM, 60 pM, 16 pM, 8 pM and 2 pM) of siRNA molecules. Luminescence was 
evaluated 24 h after transfection. n = 3 ± SD; (B) Plot of siRNAs melting temperature used 
in luciferase study. n = 3 ± SD. 
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2.2. Impact of Mismatches and/or L-Threoninol Modifications on the Silencing Activity of siRNAs 
In 2010 Maier and co-workers reported that the modulation of the thermal stability can enhance the 
potency of siRNA molecules [39]. The destabilization of the siRNA duplex could be achieved by the 
introduction of chemical modifications or on account of base pair mismatches [40,41]. The melting 
data stressed the destabilizing effects of the TL presence on the siRNA duplex (Table 1). Thus, by 
replacing the 10th and 11th positions of the antisense strand with TL, we want to investigate the impact 
of the modification on the cleavage site functionality and possible correlations between the duplex 
destabilization and the siRNA potency. The silencing activities (IC50) of the previously described 
siRNA duplexes are shown in Table 1. Luciferase experiments revealed that the modified siRNA at the 
11th position (T11A9) discloses better activity (20.2 pM) than the one modified at the 10th position 
(T10A10, 111 pM), with respect to the activity of unmodified siRNA (wt, 9.6 pM). The comparison  
of IC50 activities defines more clearly the impact of the presence of TL on the silencing ability: only  
2-fold change has been observed in the case of modification at the 11th position and around 10-fold 
change in presence of the 10th position modification (Table 1). These data allow us to conclude that 
the central positions of the antisense strand have a crucial impact on the silencing ability of siRNAs, 
likely due to alterations on the slicer activity of the Ago2 protein. 
Next, we evaluated the silencing ability of different siRNAs carrying central mismatches at the 9th 
and 10th positions of the sense strand facing either natural uridine or TL residue. The introduction of 
mismatched base pair at central positions, locally destabilizing the RNA duplex, should entail better 
silence activities of the mismatched siRNAs by the rule “higher duplex destabilization leads to increase 
potency” [42]. 
Comparing the silence ability, among the wtU9, wtC9, and wtG9 siRNAs carrying different 
mismatches at the 9th position of the sense strand and natural uridine on the antisense strand, we noted 
that the wtU9 and wtC9 siRNAs, although they own the lowest Tm (ΔTm = 7.6 and 8.5 °C 
respectively), exhibited the same or worse silence activity with respect to the wtG9 siRNA, 
characterized by the smallest change in Tm (ΔTm = 2.1 °C). Thus, the correlation between thermal 
stability and siRNA potency is not so direct. In our hands, the siRNA duplexes with lower melting 
temperature exhibited worse silencing activities. The type of mismatch (U:U; U:C; U:G) influences the 
extent of the decrease. At the 9th position of the sense strand, the mismatch U:C (wtC9) affects more 
the siRNA activity respect to U:U (wtU9) and U:G (wtG9) mismatches. Indeed, the activity of wtU9 
(15.4 pM) and wtG9 (15.8 pM) is almost preserved (wt = 9.6 pM), whereas the activity of wtC9  
(30.7 pM) revealed a larger reduction of potency (three-fold reduction). Considering the TL-modified 
siRNAs (T11U9, T11C9, and T11G9), although the potency is slightly affected with respect to natural 
mismatched siRNAs, the general silencing trend is maintained. The substitution TL:C impacted deeply 
on silencing, whereas the TL:U and TL:G mismatches disclosed better activity. Here too, the T11G9 
siRNA, characterized by the presence of the base pair TL:G, is associated with an activity (26.5 pM) 
quite similar to the parent T11A9 (20.2 pM). Furthermore, depending on the position of the 
mismatches, the activity either decreased slightly (wtU9, wtC9, wtG9, T11U9, T11C9, and T11G9) 
or is strongly diminished (wtC10, wtU10, wtG10, T10U10, T10C10, and T10G10) with respect to the 
activity of the perfect match siRNA (wt). In the case of wtU9, wtC9, and wtG9 siRNAs, the silencing 
activity was reduced between two- and three-fold (15.4, 30.7, 15.8 versus 9.6 pM), whereas wtC10 
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and wtU10 siRNAs were inactive and the wtG10 siRNA was 10-fold less potent than the perfectly 
matched (wt). Paying attention to the TL-modified siRNAs at the 10th position, we noted that the 
silencing of mismatched siRNAs with pyrimidine:pyrimidine mismatches (T10U10 and T10C10) is 
retained to some extent. Again looking to parent activity, the siRNA potency is retained in presence of 
the TL:G bulge (T10G10), in which, probably, the natural geometry of the RNA duplex is preserved. 
These observations are consistent with previous reports claiming the better tolerance of the RISC for 
wobble base pairing [43,44]. As previously described [45], the presence of central mismatches at 
positions 9 and 10 of the sense strand impairs gene silencing (Figure 3A). The integrity of the A-form 
of the RNA double helix, especially in the proximity of the cleavage site, is a pivotal feature for the 
proper functionality of the RISC [46]. Thus, more than the melting temperature and so the 
destabilization of the duplex, the siRNA potency should be linked to the local distortion around the 
cleavage site. The correlation between duplex integrity and siRNA activity is adequately supported by 
the data arisen from luciferase experiments. Irrespective of position, siRNAs carrying the U:G wobble 
base pair, closely resembling a Watson-Crick base pair, disclosed the better activity among all 
mismatched siRNAs (Figure 3A). Moreover, Patel and co-workers [47] found that contiguous base 
pairing, along the segment starting from the positions 1–10 of the antisense strand, is necessary for the 
proper activity of RNase H-mediated cleavage of the Ago2 protein. For this reason, the alteration of 
base pairing due to the presence of mismatches at the 10th position of the sense strand impacts more 
heavily on the silencing, especially compared to siRNAs bearing a mismatch at the 9th position. 
Opposing views regarding the silencing mechanism of central mismatched dsRNA claimed that central 
bulges near the cleavage site can promote or hinder a slicer-dependent unwinding [48,49]. The 
presence of L-threoninol modification at position 10 of the antisense strand could make cleavable the 
sense strand, boosting a faster slicing-dependent unwinding, or affecting the local thermodynamic base 
pair stability, which would promote a slicer-independent unwinding. However, considering the melting 
temperature of T10U10 and T10C10 siRNAs, the lowest among all the synthetized siRNAs (55.2 and 
54.1 °C, respectively) (Table 1), we thought that a bypass mechanism such as a slicer-independent 
unwinding should be at the basis of the slight retrieval activity. 
2.3. Central Mismatched siRNA: Trying to Bias the Silence 
In 2009, a report from Okamura et al. [50] stressed the importance of miRNAs duplex pairing status 
at position 9 and 10 during the strand selection of Drosophila Ago2 protein. Presence of mismatches at 
these positions drives a predominant selection for one strand of the miRNA molecule. More recent 
study [51] also confirmed that central mismatch at the 10th position of the antisense strand can bias the 
strand selection by the human Ago2 protein. Even if the strand selection by the Ago2 protein was not 
determined in this study, we wondered whether internal duplex structural features might affect the  
ON-/OFF-target activity, contributing to the design of functionally asymmetric siRNAs [52,53]. The 
individual activity of the two strands of a siRNA molecule can be adequately evaluated using  
a psiCHECK2 reporter system. Thus, eight different perfect sites for antisense strand (AS) and sense 
strand (SS; SSU9; SSC9; SSG9; SSU10; SSC10; SSG10) of the siRNA duplex (5' > 3') were inserted 
at the 3' untranslated region (3'-UTR) of the Renilla luciferase (Rluc) gene. As previously, central 
mismatches were produced substituting the A with U, C and G on positions 9 and 10 of the sense 
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strand (facing the 11 and 10 positions of the antisense strand, respectively). The silence activity of the 
sense and antisense strand of these two sets of siRNAs were separately evaluated (Figure 4). 
Mismatched siRNAs at position 9 of the sense strand (wtU9, wtC9, wtG9, T11U9, T11G9. and 
T11C9) exhibited no substantial difference between the ON-/OFF-target silencing and were 
completely comparable to the perfectly matched siRNA (wt) (Figure 4). At first glance, the group of 
mismatched siRNAs at position 10 was globally characterized by reduced ON-activity (Table 1). 
Remarkably, the wtU10 and wtC10 siRNAs were not active, whereas the similar siRNA carrying TL 
modification (T10U10 and T10C10), kept some degree of silencing (Figure 4 and Table 1). 
Unfortunately, the absence of activity of wtU10 and wtC10 siRNAs precluded further analysis on their 
ability of discrimination between ON-/OFF-target silencing. Unlike the mismatched siRNAs at the 9th 
position, L-threoninol modified siRNAs carrying mismatches at position 10 disclosed some asymmetry 
between the ON-/OFF-target silencing, in fact, siRNAs T10U10, T10C10, and T10G10 seem to 
follow a pattern dependent on mismatch type. In detail, the presence of hard mismatches, such as 
pyrimidine:pyrimidine pairings (T10U10 and T10C10) correspond to a certain bias towards the  
ON-target silencing. The T10G10 siRNA, characterized by mild pyrimidine:purine mismatch (wobble 
base pair), disclosed the worst relationship between ON-/OFF-target silencing. Of note, siRNAs with 
mild pyrimidine:purine mismatch at position 10 (wtG10 and T10G10), even maintaining the same 
ON-target potency (101 pM and 110 pM, respectively) revealed different OFF-target silencing. The 
presence of the L-threoninol unit instead of a natural uridine confers worse OFF-target silencing. In 
conclusion, not only the RNA helix geometry but also the mismatch position seems to be decisive for 
the degree of the ON-/OFF-target silencing. 
 
Figure 4. Silencing activities of antisense strand (AS) and sense strand (SS) of mismatched 
siRNAs at position 9 (left panel) and position 10 (right panel) bearing either natural uridine 
(wt) or L-threoninol-thymine (TL). To assess the on-target and off-target effects, 1 nM of 
the indicated siRNAs were co-transfected with psiCHECK2 reporters (AS or SS, SSU9, 
SSC9, SSG9, SSU10, SSC10 and SSG10, respectively) in HeLa cells. Mock transfection 
was set as 100%. n = 3 ± SD. 
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2.4. Central L-Threoninol Modified siRNAs act through an Ago2-Mediated Mechanism 
In order to demonstrate that the silencing of central L-threoninol modified siRNAs (T10A10 and 
T11A9) depends on the action of the slicer protein Ago2, we performed some RNAi experiments 
involving MEFwt and MEFAgo2−/− cells (Figure 5). In MEFAgo2−/− cells, no Renilla mRNA decrease 
neither with unmodified (wt) nor with modified (T10A10 and T11A9) siRNAs was observed. 
Conversely, in MEFwt cells, both modified (T10A10 and T11A9) siRNAs disclosed only moderate 
reduction of Renilla mRNA with respect to the wt siRNA. The presence of L-threoninol-thymine 
hindered the proper action of the Ago2 protein. Here too, the 10th position of the antisense strand 
proved to be more sensitive to modification than the 11th position. Noteworthy, the activities of modified 
(T10A10 and T11A9) siRNAs reflected the IC50 values assessed by the luciferase assay (Table 1). 
 
Figure 5. Renilla mRNA reduction in MEFwt and MEFAgo2−/− cells. 1 nM of unmodified 
(wt) and modified (T10A10 and T11A9) siRNAs were co-transfected with psiCHECK2 
(AS) reporter. After 24 h, cells were harvested for RNA extraction and qRT-PCR 
measurement. n = 2 ± SD. 
2.5. Single-Stranded siRNAs Experiments 
Finally, in order to assess the unambiguous contribution of the TL modification to the silence activity, 
some antisense single-stranded siRNA (ss-siRNA) assays were performed [20]. As depicted in Figure 6, 
the presence of the TL modification hindered the silencing, especially if compared to the unmodified  
ss-siRNA. Of note, the ss-siRNA modified with TL at the 10th position (AST10), even at the greatest 
dose transfected (100 nM), showed a pronounced reduction on activity with respect to both  
TL-modified at the 11th position (AST11) and the unmodified one (ASWT). The AST11 ss-siRNA 
retained to a certain extent the silencing ability, although it is 4-fold less potent than the ASWT. 
Probably, the alteration of the catalytic site, given by the presence of the TL modification, should be 
the cause of the reduced or abolished silencing activity. Thus, the presence of the TL modification 
could alter the optimal geometry of the active site necessary to the mRNA cleavage. Taking together 
the data that emerged from MEFAgo2−/− and ss-siRNA assays, we gather that this phenomenon is 
probably due to less efficient cleavage of the target mRNA. Besides conformational alteration at the 
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cleavage site, variation in hybridization properties of the ss-siRNA with the cognate mRNA may also 
have an influence on activity. 
 
Figure 6. Plot of antisense ss-siRNAs activities of natural (ASWT) and TL-modified  
ss-siRNAs (AST10 and AST11). Variable amounts of siRNAs (100 nM, 50 nM, 10 nM 
and 5 nM) were co-transfected with psiCHECK2 (AS) reporter in HeLa cells. 24 h  
post-transfection the luminescence were measured. n = 3 ± SD. 
2.6. Silencing Asymmetry and “Strand-Blocking” Effect of TL Modification 
Results achieved from mismatched siRNA experiments suggested us that, in contrast to other 
reports [42], the mismatches introduction at central positions of siRNA molecules did not imply 
satisfactory bias between the ON-/OFF-target silencing (Figure 4). So, central structural parameters are 
pivotal for the silencing effectiveness but not for widening the silencing asymmetry. In order to 
estimate the rules governing silencing asymmetry of siRNA molecules, we thought to investigate the 
gene-silencing effects of the introduction of some flexible unit at the 5'-end of the sense strand as the 
L-threoninol modification. Thus, we inserted a single L-threoninol unit at position 2 (from the 5'-end) 
of the sense strand of a siRNA molecule (wtT2) (Table 2). The wtT2 siRNA revealed a potency  
(13.4 pM) resembling that observed with the wt siRNA (9.6 pM), and the melting temperature subtly 
changed (ΔTm = 1.1 °C) compared to unmodified siRNA (wt) (Table 2). The presence of only one  
L-threoninol unit near the 5'-end of the sense strand completely shifted the balance towards the  
ON-target activity (Figure 7). Furthermore, important parameters such as the potency and the duplex 
stability were preserved. Moreover, to examine the mechanisms underlying the silencing asymmetry 
obtained by the wtT2 siRNA, we compared the activities of unmodified (SSWT) and position 2  
L-threoninol modified (SST2) sense ss-siRNAs (Figure 7). The SST2 ss-siRNA showed no notable 
silencing ability, whereas the SSWT ss-siRNA displayed a dose-dependent inhibition. Taking together 
the outcomes evinced from double-stranded and single-stranded siRNA experiments (Figure 7), we can 
affirm that the L-threoninol unit, impairing the gene-silencing ability of the modified sense strand, 
acted as “strand-blocking” modification. Probably, structural perturbations occurring between the sense 
seed region and the target mRNA totally blocked the sense strand activity [36]. The “strand-blocking” 
effect is even stronger in comparison with the impairment obtained by UNA modification [24]. 
Additionally, compared to other reports that achieved the same “strand-blocking” effect introducing 
Molecules 2015, 20 7612 
 
 
various modifications on both siRNA strands [22], we completely abolished the sense strand-mediated 
gene-silencing activity with the introduction of a single L-threoninol modification. 
Table 2. Sequence, potency and duplex stability properties comparison between unmodified 
and L-threoninol terminal modified siRNA. 
TTAAAAAGAGGXYGAAGUCKA-5' sense (SS) 
         5'-UUUUUCUCCZWCUUCAGAUTT antisense (AS) 
 
Antisense  
..A.. 
Sense  
..K.. 
IC50 (pM) ± SD Tm (°C) ± SD Δ Tm (wt) 
wt ..A.. ..U.. 9.6 ± 0.5 67.8 ± 0.3 -- 
wtT2 ..A.. ..TL.. 13.4 ± 0.3 66.7 ± 0.3 1.1 
 
Figure 7. (left panel) ON-/OFF-target silencing of L-threoninol modified siRNA. 
Unmodified (wt) and modified at position 2 of the sense strand (wtT2) siRNAs, at final 
concentration of 1 nM, were co-transfected with psiCHECK2 sensors (AS and SS) in HeLa 
cells. Mock transfection was set as 100%. n = 3 ± SD. (right panel) Silencing activities of 
unmodified (SSWT) and position 2 TL-modified (SST2) sense ss-siRNA in HeLa cells. 
Luminescence were determined 24 h after the co-trasfection of decreasing concentrations 
of ss-siRNAs (100 nM, 50 nM, 30 nM and 5 nM) with psiCHECK2 (SS) reporter. Mock 
trasfection was set as 100%. n = 3 ± SD. 
3. Experimental Section 
3.1. RNA Synthesis 
RNA strands containing no modifications and a TL unit at positions 10 and 11 were synthesized on 
the 0.2-μmol scale using LV200 polystyrene supports. All oligonucleotides were synthesized on  
an Applied Biosystems 394 synthesizer (Foster City, CA, USA) using commercially available reagents 
(Fluka and Sigma-Aldrich, Quimica S.A., Tres cantos, Madrid, Spain) and 2'-O-TBDMS-5'- 
O-DMT-protected phosphoramidites (ABz, Gdmf, CAc , and U) (Link Technologies, Glasgow, Scotland, 
UK). The synthesis procedure of the L-threoninol-thymine phosphoramidite was already described [20]. 
The coupling time was 15 min and the coupling yields of natural and modified phosphoramidites were 
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>97% in DMT-ON mode. SiRNAs previously described by Terrazas et al. [15] were used to design 
siRNA duplexes against the Renilla gene. 
3.2. Deprotection and Purification of Unmodified and Modified RNA Oligonucleotide 
Every solid support was treated at 55 °C for 1 h with 1.5 mL of NH3 solution (33%) and 0.5 mL of 
ethanol. Then, the suspension was cooled to room temperature; the supernatant was transferred into  
a clean tube and subsequently evaporated to dryness using a Speedvac concentrator. The obtained 
residue was dissolved in 1 M TBAF in THF (85 μL per 0.2 μmol resin) and incubated for 15 h at room 
temperature. Finally, 1 M triethylammonium acetate (TEEA) and water were added to the solution  
(0.2 μmol synthesis: 85 μL of 1 M triethylammonium acetate (TEEA) and 330 μL water). 
Oligonucleotide desalting procedure was conducted on NAP-5 columns using water as eluent and 
evaporated to dryness. The purification of oligonucleotides was carried out by HPLC (DMT-ON). 
Column: Nucleosil 120-10 C18 column (250 × 4 mm). Solvent A: 5% ACN in 0.1 M aqueous TEAAc 
(pH = 7) and solvent B: 70% ACN in 0.1 M aqueous TEAA (pH = 7). Flow rate: 3 mL/min. 
Conditions: 20 min linear gradient from 15% to 80% B and 5 min 80% B. The collected pure fractions 
were evaporated to dryness and then treated with 1 mL of 80% AcOH solution and incubated at  
room temperature for 30 min. The deprotected oligonucleotides were desalted on NAP-10 column 
using water as eluent. 
3.3. SiRNA Preparation 
SiRNA duplexes were annealed with equimolar ratios of the sense and the antisense strands in 
siRNA suspension solution (100 mM KOAc, 30 mM HEPES-KOH and 2 mM MgCl2, pH 7.4) at final 
concentration of 20 μM. Duplexes were heated at 95 °C for 5 min and slowly cooled to 4 °C. 
3.4. Thermal Denaturation Studies 
Melting curves of duplex RNAs were performed following change of absorbance at 260 nm versus 
temperature. Samples were heated from 20 °C to 80 °C, with a linear temperature ramp of 0.5 °C/min 
in a JASCO V-650 spectrophotometer (JASCO, Easton, MD, USA) equipped with a Peltier temperature 
control. All the measurements were repeated in triplicate, both the heating and cooling curves  
were measured. Buffer condition: 100 mM KOAc, 30 mM HEPES-KOH, 2 mM MgCl2, pH 7.4, 
[oligonucleotide] = 1 M. 
3.5. Cells 
HeLa cells (ATCC), MEFwt cells (ATCC) and MEFAgo2−/− cell lines (a kind gift of Dr. O’Carroll [54]) 
were maintained in monolayer culture at exponential growth in high-glucose Dulbecco modified  
Eagle medium (DMEM) (Gibco, Life Technologies, Carlsbad, CA, USA) supplemented with  
10% heat inactivated fetal bovine serum (Gibco, Life Technologies, Carlsbad, CA, USA) and  
1× penicillin/streptomycin solution (Gibco, Life Technologies, Carlsbad, CA, USA). All cell lines 
were incubated at 37 °C in a humidified environment with 5% CO2 and periodically checked for the 
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presence of mycoplasma contamination. Cell viability was monitored by Trypan Blue exclusion assay 
and was higher than 95% in all experiments. 
3.6. PsiCHECK2 on-/off-Target Reporters 
To construct the on-target (AS) and off-target (SS; SSU9; SSC9; SSG9; SSU10; SSC10; SSG10) 
reporters, 5' phosphorylated DNA sequences (Sigma-Aldrich, Quimica S.A., Tres cantos, Madrid, Spain) 
corresponding to the antisense strand target (5'-TCGAGTCAAATCTGAAGAAGGAGAAAAAGC 
and 5'-GGCCGCTTTTTCTCCTTCTTCAGATTTGAC) and sense-strand target (SS: 5'-TCGAGATT 
TTTCTCCTTCTTCAGATCGTGGC and 5'-GGCCGCCACGATCTGAAGAAGGAGAAAAATC; 
SSU9: 5'-GGCCGCCACGATCTGAAGTAGGAGAAAAATC and 5'-TCGAGATTTTTCTCCTACTTC 
AGATCGTGGC; SSC9: 5'-GGCCGCCACGATCTGAAGCAGGAGAAAAATC and 5'-TCGAGATT 
TTTCTCCTGCTTCAGATCGTGGC; SSG9: 5'-GGCCGCCACGATCTGAAGGAGGAGAAAAATC 
and 5'-TCGAGATTTTTCTCCTCCTTCAGATCGTGGC; SSU10: 5'-GGCCGCCACGATCTGAAAT 
TGGAGAAAAATC and 5'-TCGAGATTTTTCTCCATCTTCAGATCGTGGC; SSC10: 5'-GGCCGC 
CACGATCTGAAATCGGAGAAAAATC and 5'-TCGAGATTTTTCTCCGTCTTCAGATCGTGGC; 
SSG10: 5'-GGCCGCCACGATCTGAAATGGGAGAAAAATC and 5'-TCGAGATTTTTCTCCCTCT 
TCAGATCGTGGC) of the synthesized siRNAs were annealed and inserted into the XhoI and NotI 
sites of the psiCHECK2 plasmid (Promega, Madrid, Spain). The correct insertion of the sequences was 
confirmed by sequencing. 
3.7. Transfection and Luciferase Assay 
For double-stranded and single-stranded siRNA luciferase assay, HeLa cells were plated in 24-well 
tissue culture plates at density of 1 × 105 cells per well 24 h before transfection. In dose response,  
ON-/OFF-target assessment and single-stranded siRNAs experiments, 1μg of psiCHECK2 (AS) or 
psiCHECK2 (SS; SSU9; SSC9; SSG9; SSU10; SSC10; SSG10) and siRNAs at different concentrations 
were co-transfected using Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA) in accordance 
with the manufacturer’s instructions. The inhibitory effect of siRNAs on Renilla protein expression 
was measured on lysates collected 24 h after transfection using the Dual-Luciferase Reporter Assay 
System (Promega, Madrid, Spain) and a SpectraMax M5 luminometer (Molecular Devices, Sunnyvale, 
CA, USA). The ratios of Renilla luciferase (hRluc) to Photinus luciferase (hluc+) protein activities 
were normalized to mock transfection and the mock activity was set as 100%. 
3.8. Ago2-Mediated Silencing Assay 
MEFwt and MEFAgo2−/− cells were plated in 24-well tissue culture plates at a density of  
0.8 × 105 cells per well 24 h before transfection. Co-transfection of AS reported plasmid and different 
siRNAs molecules (wt, T10A10 and T11A9) at concentration of 1 nM was performed with lipofectamine 
LTX (Life Technologies, Carlsbad, CA, USA) in accordance with the manufacturer’s protocol for 
MEF. After 24 h, the samples were harvested for RNA extraction. 
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3.9. Single-Stranded siRNA 5'-End Phosphorylation 
Before transfection, 300 pmol of single-stranded antisense (ASWT; AST10; AST11) and sense 
(SSWT; SST2) siRNAs (ss-siRNAs) were incubated for 90 min at 37 °C with 100 mM of ATP and T4 
Polynucleotide kinase (3'phosphatase minus) (New England Biolabs, Ipswich, MA, USA), then for  
30 min at 65 °C to inactivate the enzyme, following the manufacturer’s instructions. 
3.10. Isolation of RNA and RT-qPCR 
Total RNA was isolated from MEFwt and MEFAgo2−/− with TRIzol reagent (Invitrogen, Carlsbad, 
CA, USA). Then, extracted RNA was quantified by NanoDrop (Thermo Scientific, Waltham, MA 
USA). Of each RNA sample, 2.5 µg was treated with DNase I [DNase I (RNase free) New England 
Biolabs] following the manufacturer’s instructions. Then, the reverse transcription reaction, 0.5 µg of 
total RNA, was carried out with random hexamer primers and Revertaid H minus RT enzyme (Thermo 
Scientific) according to the manufacturer’s instructions. First, strand cDNA was subsequently diluted  
4 times in nuclease-free water before the addition of 1 µL of resulting cDNA to the real-time mixture. 
Real-time PCR was accomplished in a total volume of 20 µL, using Maxima SYBR Green protocol 
(Thermo Scientific) following the manufacturer’s instructions. The reference gene GADPH was used 
as the internal control. Renilla silencing was calculated and represented as 2−∆∆Ct method. All primer 
pairs were purchased from Sigma-Aldrich and Primer-Blast was used as the primer designing tool [55]. 
GAPDH Fwd: 5'-TGCACCACCAACTGCTTAG; GAPDH Rev: 5'-GATGCAGGGATGATGTTC; 
hRluc Fwd: 5'-GGGCGAGAAAATGGTGCTTG; hRluc Rev: 5'-GCCCTTCTCCTTGAATGGCT. 
3.11. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism software (GraphPad, San Diego, CA, 
USA). IC50 determination was performed using non-linear regression analysis (log [inhibitor] vs. 
normalized response). 
4. Conclusions 
In conclusion, the L-threoninol-thymine modification, thanks to the lack of the sugar constraint, 
allows us to pay specific attention to the nucleobase contribution and the influence of the ribose ring 
on the active site of RISC. Also, it proved to be an extremely useful tool, not only for the 
understanding of its base pairing and ON-/OFF-target silencing properties, but also for dissecting some 
important issues regarding the sense strand activity. Furthermore, the “strand-blocking” effect achieved by 
the introduction of a single L-threoninol unit might be exploited for tailored design of functionally 
asymmetric siRNA molecules and it also renders its siRNA synthesis time and its cost effectiveness. 
Acknowledgments 
This study was supported by the European Union (MULTIFUN, NMP4-LA-2011-262943), the Spanish 
Ministry of Education (CTQ2010-20541), Generalitat de Catalunya (2009/SGR/208). CIBER-BBN is 
an initiative funded by the VI National R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider 
Molecules 2015, 20 7616 
 
 
Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the 
European Regional Development Fund. We are indebted to Dr. Elisa Pedone for her helpful advice and 
for providing technical assistance. 
Author Contributions 
A.A. and R.E. conceived and designed the experiments, A.A. and M.T. performed the experiments, 
A.A. and R.E. analyzed the data, A.A., M.T. and R.E. wrote the manuscript, R.E. supervised the project. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific 
genetic interference by double-stranded RNA in caenorhabditis elegans. Nature 1998, 391, 806–811. 
2. Elbashir, S.M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of  
21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411,  
494–498. 
3. Matranga, C.; Tomari, Y.; Shin, C.; Bartel, D.P.; Zamore, P.D. Passenger-strand cleavage facilitates 
assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 2005, 123, 607–620. 
4. Burnett, J.C.; Rossi, J.J. RNA-based therapeutics: Current progress and future prospects. Chem. Biol. 
2012, 19, 60–71. 
5. Martinez, T.; Wright, N.; Lopez-Fraga, M.; Jimenez, A.I.; Paneda, C. Silencing human genetic 
diseases with oligonucleotide-based therapies. Hum. Genet. 2013, 132, 481–493. 
6. Grijalvo, S.; Avino, A.; Eritja, R. Oligonucleotide delivery: A patent review (2010–2013).  
Expert Opin. Ther. Pat. 2014, 24, 801–819. 
7. Deng, Y.; Wang, C.C.; Choy, K.W.; Du, Q.; Chen, J.; Wang, Q.; Li, L.; Chung, T.K.; Tang, T. 
Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new 
strategies. Gene 2014, 538, 217–227. 
8. Judge, A.D.; Sood, V.; Shaw, J.R.; Fang, D.; McClintock, K.; MacLachlan, I. Sequence-dependent 
stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 2005, 
23, 457–462. 
9. Deleavey, G.F.; Damha, M.J. Designing chemically modified oligonucleotides for targeted gene 
silencing. Chem. Biol. 2012, 19, 937–954. 
10. Kole, R.; Krainer, A.R.; Altman, S. RNA therapeutics: Beyond RNA interference and antisense 
oligonucleotides. Nat. Rev. Drug Discov. 2012, 11, 125–140. 
11. Shukla, S.; Sumaria, C.S.; Pradeepkumar, P.I. Exploring chemical modifications for siRNA 
therapeutics: A structural and functional outlook. ChemMedChem 2010, 5, 328–349. 
12. Murayama, K.; Tanaka, Y.; Toda, T.; Kashida, H.; Asanuma, H. Highly stable duplex formation 
by artificial nucleic acids acyclic threoninol nucleic acid (aTNA) and serinol nucleic acid (SNA) 
with acyclic scaffolds. Chemistry 2013, 19, 14151–14158. 
Molecules 2015, 20 7617 
 
 
13. Petersen, M.; Nielsen, C.B.; Nielsen, K.E.; Jensen, G.A.; Bondensgaard, K.; Singh, S.K.; 
Rajwanshi, V.K.; Koshkin, A.A.; Dahl, B.M.; Wengel, J.; et al. The conformations of locked nucleic 
acids (LNA). J. Mol. Recognit. 2000, 13, 44–53. 
14. Elmen, J.; Thonberg, H.; Ljungberg, K.; Frieden, M.; Westergaard, M.; Xu, Y.; Wahren, B.; 
Liang, Z.; Orum, H.; Koch, T.; et al. Locked nucleic acid (LNA) mediated improvements in 
siRNA stability and functionality. Nucleic Acids Res. 2005, 33, 439–447. 
15. Terrazas, M.; Ocampo, S.M.; Perales, J.C.; Marquez, V.E.; Eritja, R. Effect of north 
bicyclo[3.1.0]hexane 2'-deoxy-pseudosugars on RNA interference: A novel class of siRNA 
modification. ChemBioChem 2011, 12, 1056–1065. 
16. Anzahaee, M.Y.; Deleavey, G.F.; Le, P.U.; Fakhoury, J.; Petrecca, K.; Damha, M.J. 
Arabinonucleic acids: 2'-stereoisomeric modulators of siRNA activity. Nucleic Acid Ther. 2014, 
24, 336–343. 
17. Dowler, T.; Bergeron, D.; Tedeschi, A.L.; Paquet, L.; Ferrari, N.; Damha, M.J. Improvements in 
siRNA properties mediated by 2'-deoxy-2'-fluoro-beta-d-arabinonucleic acid (FANA).  
Nucleic Acids Res. 2006, 34, 1669–1675. 
18. Laursen, M.B.; Pakula, M.M.; Gao, S.; Fluiter, K.; Mook, O.R.; Baas, F.; Langklaer, N.;  
Wengel, S.L.; Wengel, J.; Kjems, J.; et al. Utilization of unlocked nucleic acid (UNA) to enhance 
siRNA performance in vitro and in vivo. Mol. Biosyst. 2010, 6, 862–870. 
19. Pasternak, A.; Wengel, J. Thermodynamics of RNA duplexes modified with unlocked nucleic 
acid nucleotides. Nucleic Acids Res. 2010, 38, 6697–6706. 
20. Alagia, A.; Terrazas, M.; Eritja, R. RNA/aTNA chimeras: RNAi effects and nucleases resistance 
of single and double stranded RNAs. Molecules 2014, 19, 17872–17896. 
21. Asanuma, H.; Toda, T.; Murayama, K.; Liang, X.; Kashida, H. Unexpectedly stable artificial 
duplex from flexible acyclic threoninol. J. Am. Chem. Soc. 2010, 132, 14702–14703. 
22. Kamiya, Y.; Takai, J.; Ito, H.; Murayama, K.; Kashida, H.; Asanuma, H. Enhancement of stability 
and activity of siRNA by terminal substitution with serinol nucleic acid (SNA). ChemBioChem 2014, 
15, 2549–2555. 
23. Kashida, H.; Murayama, K.; Toda, T.; Asanuma, H. Control of the chirality and helicity of 
oligomers of serinol nucleic acid (SNA) by sequence design. Angew. Chem. Int. Ed. Engl. 2011, 
50, 1285–1288. 
24. Snead, N.M.; Escamilla-Powers, J.R.; Rossi, J.J.; McCaffrey, A.P. 5' Unlocked nucleic acid 
modification improves siRNA targeting. Mol. Ther. Nucleic Acids 2013, 2, e103. 
25. Haringsma, H.J.; Li, J.J.; Soriano, F.; Kenski, D.M.; Flanagan, W.M.; Willingham, A.T. MRNA 
knockdown by single strand RNA is improved by chemical modifications. Nucleic Acids Res. 
2012, 40, 4125–4136. 
26. Kandeel, M.; Kitade, Y. Computational analysis of siRNA recognition by the Ago2 Paz domain 
and identification of the determinants of RNA-induced gene silencing. PLoS ONE 2013, 8, e57140. 
27. Deleavey, G.F.; Frank, F.; Hassler, M.; Wisnovsky, S.; Nagar, B.; Damha, M.J. The 5' binding 
Mid domain of human Argonaute2 tolerates chemically modified nucleotide analogues.  
Nucleic Acid Ther. 2013, 23, 81–87. 
Molecules 2015, 20 7618 
 
 
28. Jackson, A.L.; Burchard, J.; Leake, D.; Reynolds, A.; Schelter, J.; Guo, J.; Johnson, J.M.; Lim, L.; 
Karpilow, J.; Nichols, K.; et al. Position-specific chemical modification of siRNAs reduces  
“off-target” transcript silencing. RNA 2006, 12, 1197–1205. 
29. Somoza, A.; Terrazas, M.; Eritja, R. Modified siRNAs for the study of the Paz domain.  
Chem. Commun. 2010, 46, 4270–4272. 
30. Efthymiou, T.C.; Peel, B.; Huynh, V.; Desaulniers, J.P. Evaluation of siRNAs that contain internal 
variable-length spacer linkages. Bioorganic Med. Chem. Lett. 2012, 22, 5590–5594. 
31. Valdmanis, P.N.; Gu, S.; Schuermann, N.; Sethupathy, P.; Grimm, D.; Kay, M.A. Expression 
determinants of mammalian Argonaute proteins in mediating gene silencing. Nucleic Acids Res. 
2012, 40, 3704–3713. 
32. Aleman, L.M.; Doench, J.; Sharp, P.A. Comparison of siRNA-induced off-target RNA and 
protein effects. RNA 2007, 13, 385–395. 
33. Caffrey, D.R.; Zhao, J.; Song, Z.; Schaffer, M.E.; Haney, S.A.; Subramanian, R.R.; Seymour, A.B.; 
Hughes, J.D. SiRNA off-target effects can be reduced at concentrations that match their individual 
potency. PLoS ONE 2011, 6, e21503. 
34. Schwarz, D.S.; Hutvagner, G.; Du, T.; Xu, Z.; Aronin, N.; Zamore, P.D. Asymmetry in the 
assembly of the RNAi enzyme complex. Cell 2003, 115, 199–208. 
35. Khvorova, A.; Reynolds, A.; Jayasena, S.D. Functional siRNAs and miRNAs exhibit strand bias.  
Cell 2003, 115, 209–216. 
36. Ui-Tei, K.; Naito, Y.; Nishi, K.; Juni, A.; Saigo, K. Thermodynamic stability and Watson-Crick 
base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based  
off-target effect. Nucleic Acids Res. 2008, 36, 7100–7109. 
37. Gu, S.; Zhang, Y.; Jin, L.; Huang, Y.; Zhang, F.; Bassik, M.C.; Kampmann, M.; Kay, M.A.  
Weak base pairing in both seed and 3' regions reduces RNAi off-targets and enhances si/shRNA 
designs. Nucleic Acids Res. 2014, 42, 12169–12176. 
38. Varani, G.; McClain, W.H. The G x U wobble base pair. A fundamental building block of RNA 
structure crucial to RNA function in diverse biological systems. EMBO Rep. 2000, 1, 18–23. 
39. Addepalli, H.; Meena; Peng, C.G.; Wang, G.; Fan, Y.; Charisse, K.; Jayaprakash, K.N.; Rajeev, K.G.; 
Pandey, R.K.; Lavine, G.; et al. Modulation of thermal stability can enhance the potency of 
siRNA. Nucleic Acids Res. 2010, 38, 7320–7331. 
40. Bramsen, J.B.; Pakula, M.M.; Hansen, T.B.; Bus, C.; Langkjaer, N.; Odadzic, D.; Smicius, R.; 
Wengel, S.L.; Chattopadhyaya, J.; Engels, J.W.; et al. A screen of chemical modifications 
identifies position-specific modification by UNA to most potently reduce siRNA off-target 
effects. Nucleic Acids Res. 2010, 38, 5761–5773. 
41. Petrova, N.S.; Meschaninova, M.I.; Venyaminova, A.G.; Zenkova, M.A.; Vlassov, V.V.; 
Chernolovskaya, E.L. Silencing activity of 2'-o-methyl modified anti-mdr1 siRNAs with 
mismatches in the central part of the duplexes. FEBS Lett. 2011, 585, 2352–2356. 
42. Wu, H.; Ma, H.; Ye, C.; Ramirez, D.; Chen, S.; Montoya, J.; Shankar, P.; Wang, X.A.; Manjunath, N. 
Improved siRNA/shRNA functionality by mismatched duplex. PLoS ONE 2011, 6, e28580. 
43. Saxena, S.; Jonsson, Z.O.; Dutta, A. Small RNAs with imperfect match to endogenous mRNA 
repress translation. Implications for off-target activity of small inhibitory RNA in mammalian 
cells. J. Biol. Chem. 2003, 278, 44312–44319. 
Molecules 2015, 20 7619 
 
 
44. Holen, T.; Moe, S.E.; Sorbo, J.G.; Meza, T.J.; Ottersen, O.P.; Klungland, A. Tolerated wobble 
mutations in siRNAs decrease specificity, but can enhance activity in vivo. Nucleic Acids Res.  
2005, 33, 4704–4710. 
45. Leuschner, P.J.; Ameres, S.L.; Kueng, S.; Martinez, J. Cleavage of the siRNA passenger strand 
during RISC assembly in human cells. EMBO Rep. 2006, 7, 314–320. 
46. Rana, T.M. Illuminating the silence: Understanding the structure and function of small RNAs. 
Nat. Rev. Mol. Cell Biol. 2007, 8, 23–36. 
47. Wang, Y.; Juranek, S.; Li, H.; Sheng, G.; Tuschl, T.; Patel, D.J. Structure of an Argonaute 
silencing complex with a seed-containing guide DNA and target RNA duplex. Nature 2008, 456, 
921–926. 
48. Yoda, M.; Kawamata, T.; Paroo, Z.; Ye, X.; Iwasaki, S.; Liu, Q.; Tomari, Y. ATP-dependent 
human RISC assembly pathways. Nat. Struct. Mol. Biol. 2010, 17, 17–23. 
49. Gu, S.; Jin, L.; Zhang, F.; Huang, Y.; Grimm, D.; Rossi, J.J.; Kay, M.A. Thermodynamic stability 
of small hairpin RNAs highly influences the loading process of different mammalian Argonautes. 
Proc. Natl. Acad. Sci. USA 2011, 108, 9208–9213. 
50. Okamura, K.; Liu, N.; Lai, E.C. Distinct mechanisms for microRNA strand selection by 
drosophila Argonautes. Mol. Cell 2009, 36, 431–444. 
51. Noland, C.L.; Doudna, J.A. Multiple sensors ensure guide strand selection in human RNAi 
pathways. RNA 2013, 19, 639–648. 
52. Du, Q.; Thonberg, H.; Wang, J.; Wahlestedt, C.; Liang, Z. A systematic analysis of the silencing 
effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res. 2005, 
33, 1671–1677. 
53. Wei, J.X.; Yang, J.; Sun, J.F.; Jia, L.T.; Zhang, Y.; Zhang, H.Z.; Li, X.; Meng, Y.L.; Yao, L.B.; 
Yang, A.G. Both strands of siRNA have potential to guide posttranscriptional gene silencing in 
mammalian cells. PLoS ONE 2009, 4, e5382. 
54. O’Carroll, D.; Mecklenbrauker, I.; Das, P.P.; Santana, A.; Koenig, U.; Enright, A.J.; Miska, E.A.; 
Tarakhovsky, A. A slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA 
pathway. Genes Dev. 2007, 21, 1999–2004. 
55. Ye, J.; Coulouris, G.; Zaretskaya, I.; Cutcutache, I.; Rozen, S.; Madden, T.L. Primer-blast: A tool 
to design target-specific primers for polymerase chain reaction. BMC Bioinform. 2012, 13, 
doi:10.1186/1471-2105-13-134. 
Sample Availability: Samples of the compounds are not available from the authors. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
